Differentiated Thyroid Carcinoma and Intestinal Polyposis Syndromes

Publisher： Bentham Science Publishers

E-ISSN： 2212-3873|12|4|377-381

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.12, Iss.4, 2012-12, pp. : 377-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thyroglobulin Autoantibodies as Surrogate Biomarkers in the Management of Patients with Differentiated Thyroid Carcinoma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 32, 2014-10 ,pp. : 3687-3692

Bentham Science Publishers

Access to resources Recommend Favorite

Thyroid Carcinoma

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 6, 2007-07 ,pp. : 568-568

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

The therapeutic management of differentiated thyroid cancer

By Sipos Jennifer A   Mazzaferri Ernest L  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2627-2637

Informa Healthcare

Access to resources Recommend Favorite

Genetic Alterations in Differentiated Thyroid Cancers

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 3, 2009-09 ,pp. : 257-268

Bentham Science Publishers

Access to resources Recommend Favorite

18F-FDG-PET/CT in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan. It's Value Confirmed by a Bicentric Experience

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 3, 2016-12 ,pp. : 228-234

Bentham Science Publishers

Access to resources Recommend Favorite